Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of SLC2A6 mRNA | CTD | PMID:32512070 | 1,2-dichloroethane | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of SLC2A6 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC2A6 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | SLC2A6 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC2A6 mRNA | CTD | PMID:30165855 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A6 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A6 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A6 mRNA | CTD | PMID:19933214 and PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A6 mRNA | CTD | PMID:21570461 and PMID:26377647 | 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | 2-palmitoylglycerol | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of SLC2A6 mRNA | CTD | PMID:37199045 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Slc2a6 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of SLC2A6 exon | CTD | PMID:33297965 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SLC2A6 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of SLC2A6 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SLC2A6 mRNA | CTD | PMID:33354967 | aldehydo-D-glucosamine | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | aldehydo-D-glucose | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucose results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | antimycin A | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | antirheumatic drug | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SLC2A6 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SLC2A6 mRNA | CTD | PMID:33212167 | atrazine | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of SLC2A6 mRNA | CTD | PMID:22378314 | benzene | affects expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Benzene affects the expression of SLC2A6 mRNA | CTD | PMID:21147609 | benzo[a]pyrene | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA | CTD | PMID:27858113 | benzo[b]fluoranthene | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of SLC2A6 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA | CTD | PMID:27858113 | Benzo[k]fluoranthene | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of SLC2A6 mRNA | CTD | PMID:26377693 | beta-D-glucosamine | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucosamine results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC2A6 mRNA | CTD | PMID:25181051 | buta-1,3-diene | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of SLC2A6 mRNA | CTD | PMID:29038090 | butanal | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of SLC2A6 mRNA | CTD | PMID:26079696 | caffeine | affects phosphorylation | ISO | SLC2A6 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SLC2A6 protein | CTD | PMID:35688186 | cannabidiol | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Cannabidiol results in increased expression of SLC2A6 mRNA | CTD | PMID:21542829 | carbon nanotube | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC2A6 gene | CTD | PMID:20938992 | chrysene | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA | CTD | PMID:27858113 | cisplatin | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SLC2A6 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | SLC2A6 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SLC2A6 mRNA | CTD | PMID:27392435 | cyclophosphamide | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Cyclophosphamide results in increased expression of SLC2A6 mRNA | CTD | PMID:21527772 | cyclosporin A | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC2A6 mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLC2A6 mRNA | CTD | PMID:25562108 | D-glucose | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucose results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | deguelin | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | deguelin results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | dexamethasone | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of SLC2A6 mRNA | CTD | PMID:22733784 | dexamethasone | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of SLC2A6 mRNA | CTD | PMID:25047013 | dimethyl sulfoxide | affects expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide affects the expression of SLC2A6 mRNA | CTD | PMID:24834073 | doxorubicin | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC2A6 mRNA | CTD | PMID:29803840 | ethanol | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Ethanol results in increased expression of SLC2A6 mRNA | CTD | PMID:19167417 | ethanol | affects expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Ethanol affects the expression of SLC2A6 mRNA | CTD | PMID:30319688 | etoposide | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Etoposide results in increased expression of SLC2A6 mRNA | CTD | PMID:21527772 | folic acid | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SLC2A6 mRNA | CTD | PMID:33387578 | glucose | decreases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Glucose results in decreased expression of SLC2A6 mRNA | CTD | PMID:17178593 | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of SLC2A6 mRNA | CTD | PMID:20080153 | L-methionine | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC2A6 gene | CTD | PMID:20938992 | lipopolysaccharide | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of SLC2A6 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | SLC2A6 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | methyl methanesulfonate | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SLC2A6 mRNA | CTD | PMID:21527772 | nickel atom | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Nickel results in increased expression of SLC2A6 mRNA | CTD | PMID:25583101 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A6 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC2A6 mRNA | CTD | PMID:33387578 | pentanal | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | pentanal results in increased expression of SLC2A6 mRNA | CTD | PMID:26079696 | picoxystrobin | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | pioglitazone | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SLC2A6 mRNA | CTD | PMID:27935865 | propanal | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of SLC2A6 mRNA | CTD | PMID:26079696 | pyrimidifen | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | pyrimidifen results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | rotenone | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SLC2A6 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | Slc2a6 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SLC2A6 mRNA | CTD | PMID:23221170 and PMID:29341224 | sunitinib | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC2A6 mRNA | CTD | PMID:31533062 | tebufenpyrad | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | temozolomide | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of SLC2A6 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC2A6 mRNA | CTD | PMID:32741896 | tetraphene | multiple interactions | ISO | Slc2a6 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA | CTD | PMID:27858113 | thapsigargin | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of SLC2A6 mRNA | CTD | PMID:22378314 | thifluzamide | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | thifluzamide results in decreased expression of SLC2A6 mRNA | CTD | PMID:33512557 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SLC2A6 mRNA | CTD | PMID:23411599 and PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A6 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC2A6 mRNA | CTD | PMID:33387578 | tunicamycin | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of SLC2A6 mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Urethane results in decreased expression of SLC2A6 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC2A6 mRNA | CTD | PMID:29154799 | valproic acid | increases methylation | ISO | SLC2A6 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SLC2A6 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC2A6 mRNA | CTD | PMID:23179753 | zidovudine | increases expression | ISO | SLC2A6 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC2A6 mRNA | CTD | PMID:24292225 | |